Pulmonary embolism in a patient with multiple myeloma receiving thalidomide-dexamethasone therapy

Int J Hematol. 2008 Jun;87(5):542-544. doi: 10.1007/s12185-008-0071-x. Epub 2008 Apr 15.

Abstract

Massive pulmonary embolism is an uncommon complication of multiple myeloma treated with thalidomide-dexamethasone regimen. In 2006, multiple myeloma was diagnosed in a 72-year-old man, who received thalidomide-dexamethasone therapy. In January 2007, echocardiography and computerized tomography identified massive pulmonary embolism in the pulmonary arteries and a deep vein thrombus of the right leg. The patient also had an elevated concentration of B-type natriuretic peptide. After heparinization and warfarin therapy, the patient's condition improved. This is the first report of a patient with a rare complication of pulmonary embolism from thalidomide-treated multiple myeloma.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Humans
  • Male
  • Multiple Myeloma / blood
  • Multiple Myeloma / diagnostic imaging
  • Multiple Myeloma / drug therapy*
  • Natriuretic Peptide, Brain / blood
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / chemically induced*
  • Pulmonary Embolism / diagnostic imaging
  • Radiography
  • Thalidomide / administration & dosage
  • Thalidomide / adverse effects
  • Ultrasonography
  • Venous Thrombosis / blood
  • Venous Thrombosis / chemically induced
  • Venous Thrombosis / diagnostic imaging

Substances

  • Natriuretic Peptide, Brain
  • Thalidomide
  • Dexamethasone